GWW vs RYTM · P/E 27, rev $9.76B vs rev $131.4M
WW Grainger Inc (GWW) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported RYTM revenue for 2026-06-30 was $131.4M. Net income was -$104.9M. RYTM currently screens at market cap $6.49B.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the GWW and RYTM stock pages for the full models.
Not investment advice.